journal article·2019-11-20Open access

Biocompatible Layers Obtained from Functionalized Iron Oxide Nanoparticles in Suspension

Daniela Predoi, Simona Liliana Iconaru, Mihai Valentin Predoi, Nicolas Buton, Christelle Megier, Mikael Motelica-Heino

Coatings· Volume 9· Issue 12

Abstract

Iron oxide nanoparticles have been extensively studied for challenges in applicable areas such as medicine, pharmacy, and the environment. The functionalization of iron oxide nanoparticles with dextran opens new prospects for application. Suspension characterization methods such as dynamic light scattering (DLS) and zeta potential (ZP) have allowed us to obtain information regarding the stability and hydrodynamic diameter of these suspended particles. For rigorous characterization of the suspension of dextran-coated iron oxide nanoparticles (D-MNPs), studies have been performed using ultrasound measurements. The results obtained from DLS and ZP studies were compared with those obtained from ultrasound measurements. The obtained results show a good stability of D-MNPs. A comparison between the D-MNP dimension obtained from transmission electron microscopy (TEM), X-ray diffraction (XRD), and DLS studies was also performed. A scanning electron spectroscopy (SEM) image of a surface D-MNP layer obtained from the stable suspension shows that the particles are spherical in shape. The topographies of the elemental maps of the D-MNP layer showed a uniform distribution of the constituent elements. The homogeneity of the layer was also observed. The morphology of the HeLa cells incubated for 24 and 48 h with the D-MNP suspension and D-MNP layers did not change relative to the morphology presented by the control cells. The cytotoxicity studies conducted at different time intervals have shown that a slight decrease in the HeLa cell viability after 48 h of incubation for both samples was observed.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Iron oxide chemistry and applications · Nanoparticle-Based Drug Delivery · Electrostatics and Colloid Interactions

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

National Institute of Materials Physics, 405A Atomistilor Street, P.O. Box MG7, 077125 Magurele, Romania

Department of Mechanics, University Politehnica of Bucharest, BN 002, 313 Splaiul Independentei, Sector 6, 10023 Bucharest, Romania

HORIBA Jobin Yvon S.A.S., 6-18, Rue du Canal, 91165 Longjumeau CEDEX, France

Institut des Sciences de la Terre D’Orleans (ISTO), UMR, 327, Centre National de la Recherche Scientifique CNRS Université d’Orléans, 1A rue de la Férollerie, CEDEX 2, 45071 Orléans, France

Funding

Romanian Ministry of Research and Innovation -UEFISCDI

References (42)

Show source-provided references
1. Nanotechniques and approaches in biotechnology10.1016/S0167-7799(00)01536-5 ↗
2. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications10.1016/j.biomaterials.2004.10.012 ↗
3. Therapies targeting cancer stem cells: Current trends and future challenges10.4252/wjsc.v7.i9.1185 ↗
4. Magnetic nanoparticles: Synthesis, protection, functionalization, and application10.1002/anie.200602866 ↗
5. Applications of magnetic nanoparticles in biomedicine10.1088/0022-3727/36/13/201 ↗
6. Formation and characterization of biobased magnetic nanoparticles double coated with dextran and chitosan by layer-by-layer deposition10.1016/j.colsurfa.2014.03.004 ↗
7. Dextran-coated iron oxide nanoparticles: A versatile platform for targeted molecular imaging, molecular diagnostics, and therapy10.1021/ar200084x ↗
8. Magnetic iron oxide nanoparticles: Synthesis, stabilization, vectorization, physico-chemical characterizations, and biological applications10.1021/cr068445e ↗
9. Magnetic composite thin films of FexOy nanoparticles and photocross linked dextran hydrogels10.1016/j.jmmm.2011.11.039 ↗
10. Use of magnetic nanoparticle heating in the treatment of breast cancer10.1049/ip-nbt:20055018 ↗
11. Selective inductive heating of lymph nodes10.1097/00000658-195710000-00007 ↗
12. High-gradient magnetic capture of ferrofluids: Implications for drug targeting and tumor immobilization
13. Superparamagneticiron oxide contrast agents: Physicochemical characteristics and applications in MR imaging10.1007/s003300100908 ↗
14. Superparamagneticagents in magneticresonanc e imaging: Physiochemical characteristics and clinical applications—A review10.3109/10611869808997890 ↗
15. Magnetic properties and biological activity evaluation of iron oxide nanoparticles
16. Synthesis, surface modification and characterisation of biocompatible magnetic iron oxide nanoparticles for biomedical applications10.3390/molecules18077533 ↗
17. Core-shell structure and magnetic properties of magnetite magnetic fluids stabilized with dextran10.1016/j.apsusc.2005.01.027 ↗
18. Syusaburo, H., and Masalatsu, H. (1978). Magnetic Iron Oxide–Dextran Complex and Process for Its Production. (No. 4,101,435), U.S. Patent.
19. Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells10.1016/0022-1759(82)90007-2 ↗
20. Bunn, J.P.A., Chan, D.C., and Kirpotin, D. (1995). Magnetic Microparticles. (No. 5,411,730), U.S. Patent.
21. Mussel-inspired modification of dextran for protein-resistant coatings of titanium oxide10.1016/j.carbpol.2013.05.064 ↗
22. Magnetic nanoparticles for theragnostics10.1016/j.addr.2009.03.007 ↗
23. Predoi, D., Iconaru, S.L., and Predoi, M.V. (2019). Dextran-coated zinc-doped hydroxyapatite for biomedical applications. Polymers, 11.10.3390/polym11050886 ↗
24. Synthesis, properties, and applications of magnetic iron oxide nanoparticles10.1016/j.pcrysgrow.2008.08.003 ↗
25. Synthesis of γ–Fe2O3 nanoparticles with crystallographic and magnetic texture
26. Synthesis, characterization and MRI application of dextran-coated Fe3O4 magnetic nanoparticles10.1016/j.bej.2008.07.009 ↗
27. Cullity, B.D. (2000). Elements of X-ray Diffraction, Prentice-Hall International. [3rd ed.].
28. Particle size distributions of silver nanoparticles at environmentally relevant conditions10.1016/j.chroma.2009.07.021 ↗
29. Huang, J., Li, Q., Sun, D., Lu, Y., Su, Y., Yang, X., Wang, H., Wang, Y., Shao, W., and He, N. (2007). Biosynthesis of silver and gold nanoparticles by novel sundried Cinnamomum camphora leaf. Nanotechnology, 18.10.1088/0957-4484/18/10/105104 ↗
30. Induction heating studies of dextran coated MgFe2O4 nanoparticles for magnetic hyperthermia10.1039/C2DT31114C ↗
31. Biomedical applications of stereoscopy for three-dimensional surface reconstruction in scanning electron microscopes10.9729/AM.2016.46.2.71 ↗
32. Morphology and composition of nanocrystalline stabilized zirconia using SEM-EDS system
33. (2019, August 01). ImageJ, Available online: http://imagej.nih.gov/ij.
34. A novel L1 retrotransposon marker for HeLa cell line identification10.2144/000113089 ↗
35. The cytotoxicity of dextran-coated iron oxide nanoparticles on Hela and MCF-7 cancerous cell lines10.29252/arakmu.11.5.31 ↗
36. Toxicity of metal oxide nanoparticles in mammalian cells10.1080/10934520600966177 ↗
37. Toxicity and tissue distribution of magnetic nanoparticles in mice10.1093/toxsci/kfj027 ↗
38. Size-dependent toxicity of metal oxide particles-a comparison between nano-and micrometer size10.1016/j.toxlet.2009.03.014 ↗
39. Synthesis, characterization and toxicological evaluation of iron oxide nanoparticles in human lung alveolar epithelial cells10.1016/j.colsurfb.2014.06.064 ↗
40. Copper oxide nanoparticles are highly toxic: A comparison between metal oxide nanoparticles and carbon nanotubes10.1021/tx800064j ↗
41. The influence of surface functionalization on the enhanced internalization of magnetic nanoparticles in cancer cells10.1088/0957-4484/20/11/115103 ↗
42. Biocompatibility of Fe3O4 nanoparticles evaluated by in vitro cytotoxicity assays using normal, glia and breast cancer cells10.1088/0957-4484/21/7/075102 ↗